Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.3180
-0.0020 (-0.63%)
At close: Jun 13, 2025, 4:00 PM
0.3040
-0.0140 (-4.40%)
After-hours: Jun 13, 2025, 7:58 PM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $5.85 million as of June 13, 2025. Its market cap has decreased by -91.43% in one year.
Market Cap
5.85M
Enterprise Value
5.05M
1-Year Change
-91.43%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $5.85M, a decrease of -91.14%. That is a compound annual growth rate of -71.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2025 | 5.89M | -77.85% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.99B |
| Johnson & Johnson | 376.94B |
| Novo Nordisk | 357.59B |
| AbbVie | 339.89B |
| UnitedHealth Group | 288.92B |
| Abbott Laboratories | 237.40B |
| Novartis AG | 236.22B |
| AstraZeneca | 232.37B |